Infectious Diseases and Management After Cardiac Surgery
The development of infectious diseases and/or inflammatory-related complications in postoperative cardiac surgical patient represents a diverse and complex array of clinical scenarios that may impact and complicate the hospital course of this patient population. Infectious diseases are different from other coexisting medical conditions in several respects. First, patients may have coexisting infectious diseases that may impact perioperative care when they come for surgery—these infections may be manifest or occult. Preexisting infectious diseases may be the reason for the surgery or may alter the risks associated with the surgery. Second, every patient undergoing surgery is at risk of acquiring an infectious disease during the perioperative period. Patients undergoing surgery are vulnerable to infection both at the surgical site and where natural defenses are breached, such as the respiratory tract, urinary tract, bloodstream, and sites of invasive monitoring. Acquired infectious diseases can be passed on to other patients and to health professionals in the perioperative period, and healthcare workers themselves may serve as active agents in transmitting infectious diseases to patients.
KeywordsSurgical site infections Sternal wound infections Bloodstream infections Deep sternal wound infections Catheter-related infections Clostridium difficile infection Infectious diseases in post-cardiac transplant recipients Mycobacterium chimaera infection
- Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Jea-Benacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving sepsis campaign: guidelines for management of severe sepsis and shock. Intensive Care Med. 2008;34:17–60.CrossRefPubMedGoogle Scholar
- Haller S, Höller C, Jacobshagen A, Hamouda O, Sin MA, Monnet DL, Plachouras D, Eckmanns T. Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016. Euro Surveill. 2016;21. https://doi.org/10.2807/1560-7917.ES.2016.21.17.30215.
- Kohler P, Kuster SP, Bloemberg G, Schulthess B, Frank M, Tanner FC, Rössle M, Böni C, Falk V, Wilhelm MJ. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J. 2015;36:2745–53.CrossRefPubMedGoogle Scholar